John Kiely
At a glance: John Kiely is Director at Amneal Pharmaceuticals (AMRX). Their latest SEC Form 4, filed Aug 14, 2026, reported a sale of $882K. On file: 0 purchase lines ($0) and 1 sale line ($882K).
Disclosed holdings: about $4.5M of AMRX stock: 210,252 shares reported on their latest Form 4 (filed Aug 14, 2026), valued at the Nov 20, 2026 close of $21.29. This counts only AMRX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Amneal Pharmaceuticals, Inc. (AMRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
John Kiely's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $44K a trade.
- Bump outward: a purchase (2)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Frank P. LanutoSee Remarks · STGW · 100% match
- Marc SuidanCFO · BLZE · 100% match
- Deval L. PatrickDirector · TOST · 99% match
- Mark E. Ferguson IIIDirector · PCG · 99% match
- Laura C. KendallDirector · HTB · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2020
From the SEC's insider data sets: each open-market buy by John Kiely, matched to how the stock did over the next 90 days against the S&P 500.
0 of 1 buy beat the S&P 500 (0%), median -20.7% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| AMRX | May 19, 2020 | -20.7% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
Follow John Kiely
Get one email when John Kiely files a new purchase or sale. Free.
At most one email a day about John Kiely, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.